Sign Up Today and Learn More About PharmEasy Stock
Invest in or calculate the value of your shares in PharmEasy or other pre-IPO companies through EquityZen's platform.
About PharmEasy Stock
Founded
2015
Total Funding
2.4B
Industries
Software, Artificial Intelligence, Data and Analytics
PharmEasy is - Pharmacy made Easy. We are one of the largest pharmacy aggregators in India. We help patients connect with local pharmacy stores and diagnostic centres in order to fulfil their extensive medical needs. We believe that everyone should have access to good health.
PharmEasy Press Mentions
Stay in the know about the latest news on PharmEasy
Vuno continues 'aggressive' global expansion with $7M investment and more briefs
mobihealthnews • Feb 25, 2026
Stop downloading health apps: Samsung just put the entire doctor’s office in your pocket
techlusive • Feb 21, 2026
Samsung Health partners with PharmEasy and Tata 1mg, brings Find Care feature
timesofindia • Feb 19, 2026
Samsung Health will soon let you order medicines, book diagnostic tests, consult doctors in India
sammobile • Feb 19, 2026
Samsung Galaxy users can soon order medicines, book tests from Health app
business-standard • Feb 19, 2026
Investors in PharmEasy
Discover investors in PharmEasy stock and explore their portfolio companies
PharmEasy Management
Leadership team at PharmEasy
Chief Executive Officer
Dharmil Sheth
Chief Technology Officer
Bhaskar Raju
Join now and verify your accreditation status to gain access to:
- PharmEasy Current Valuation
- PharmEasy Stock Price
- PharmEasy Management
- Available deals in PharmEasy and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PharmEasy Cap Table and Funding History by Share Class and Liquidity Preferences
- PharmEasy Revenue and Financials
- PharmEasy Highlights
- PharmEasy Business Model
- PharmEasy Risk Factors
- PharmEasy Research Report from SACRA Research
Trading PharmEasy Stock
How to invest in PharmEasy stock?
Accredited investors can buy pre-IPO stock in companies like PharmEasy through EquityZen funds. These investments are made available by existing PharmEasy shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell PharmEasy stock?
Shareholders can sell their PharmEasy stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
